Neurofibromatosis 2 Updates

Long-term outcomes of stereotactic radiosurgery for intracranial schwannoma in #neurofibromatosis type 2: a genetic analysis perspective dlvr.it/T0h0WD

Resiliency outcomes after participation in an asynchronous web-based platform for adults with #neurofibromatosis: The NF-Web study dlvr.it/T0Zss3

Identification of hub genes and drug candidates for #NF2-related vestibular schwannoma by bioinformatics tools dlvr.it/T0R7RB

Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With #NF2-Related Schwannomatosis dlvr.it/T0G5fR

Case report of selumetinib as a novel therapy in a #neurofibromatosis type 2-associated ependymoma dlvr.it/SzrMct

Extraordinary Speech and Language Outcomes After Auditory Brainstem Implantation: Guidance From a Case Study dlvr.it/SzlGmf

Bilateral intracochlear schwannomas: histopathological confirmation and outcomes following tumour removal and cochlear implantation with lateral wall electrodes dlvr.it/SzCr0S

Cotargeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of #NF2 Schwannoma Cells dlvr.it/SyJJj8

Schwannomatosis: a Realm Reborn: year one dlvr.it/SyFqNd

Management of Bevacizumab-Induced Proteinuria Using an Angiotensin Receptor Blocker (ARB) in a Neurofibromatosis Type 2 (NF-2) Patient With Vestibular Schwannoma dlvr.it/SyBYmG

Simultaneous Inhibition of PI3K and PAK in Preclinical Models of Neurofibromatosis Type 2-related Schwannomatosis dlvr.it/Sy1zkP

Surgical management of sporadic and schwannomatosis-associated pelvic schwannomas dlvr.it/SxplcV

Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in #neurofibromatosis type 2-related schwannomatosis patients dlvr.it/SxWDPN

Meningiomas in patients with #neurofibromatosis type 2 predominantly comprise 'immunogenic subtype' tumours characterised by macrophage infiltration dlvr.it/SwfRtp

Schwannoma, Neurofibromatosis Type 2, and Schwannomatosis in the 2021 WHO Classification of Tumors of the Central Nervous System dlvr.it/SwYrJC

Neurofibromatosis- and schwannomatosis-associated tumors: Approaches to genetic testing and counseling considerations dlvr.it/SwQbJg

Long-term clinical outcomes of stereotactic radiotherapy for bilateral vestibular schwannomas in #neurofibromatosis type 2 patients dlvr.it/Sw3JLc

Longitudinal Performance of Cochlear Implants in Neurofibromatosis Type 2 dlvr.it/Sw0ZfV

Proteasomal pathway inhibition as a potential therapy for #NF2-associated meningioma and schwannoma dlvr.it/Svj4kG

Electrically evoked auditory responses: A classification for brainstem implant placement in Neurofibromatosis Type 2 dlvr.it/SvYP85